Tomorrow Is Not Likely To Be Same For Editas Medicine Inc (EDIT)

Editas Medicine Inc (EDIT) concluded trading on Wednesday at a closing price of $2.56, with 9.52 million shares of worth about $24.36 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 111.57% during that period and on July 02, 2025 the price saw a […]

Editas Medicine Inc (EDIT) Volatility Spurs A Quest For Clarity

Currently, there are 83.71M common shares owned by the public and among those 82.95M shares have been available to trade. The company’s stock has a 5-day price change of 1.90% and 62.74% over the past three months. EDIT shares are trading 68.50% year to date (YTD), with the 12-month market performance down to -61.02% lower. […]

Some Investing Thoughts On Editas Medicine Inc (NASDAQ: EDIT)

Editas Medicine Inc (EDIT) concluded trading on Thursday at a closing price of $2.18, with 3.15 million shares of worth about $6.86 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -2.24% during that period and on June 12, 2025 the price saw a […]

Look For Institutional Buying In Editas Medicine Inc (NASDAQ: EDIT)

The Vanguard Group, Inc. has recently announced that it has increased stake in Editas Medicine Inc (NASDAQ:EDIT) by 4.53%. After grabbing 8.41 million shares, the institutional investor is now in possession of 0.36 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 10.30% having worth around $88.58 million. […]

Life Telegraph
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.